1,3,6-三羟基-2-甲基蒽醌-3-O-新橙皮糖苷 | 87686-88-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 中文名称: 1,3,6-三羟基-2-甲基蒽醌-3-O-新橙皮糖苷
• 英文名称: 2-methyl-1,3,6-trihydroxy-9,10-anthraquinone 3-O-α-rhamnosyl(1→2)-β-glucoside
• 英文别名: 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside；3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,6-dihydroxy-2-methylanthracene-9,10-dione
• CAS: 87686-88-2
• 化学式: C₂₇H₃₀O₁₄
• 分子量: 578.527
• InChiKey: UMBHTGLJTANWCB-ICXAYODDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  41
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  233
• 氢给体数：
  8
• 氢受体数：
  14

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  1,3,6-三羟基-2-甲基蒽醌-3-O-Α-鼠李糖-(1→2)-Β-D-(6'-O-乙酰基)-葡萄糖苷	2-methyl-1,3,6-trihydroxy-9,10-anthraquinone 3-O-(6'-O-acetyl)-α-rhamnosyl(1→2)-β-glucoside	87686-87-1	C29H32O15	620.564

反应信息

• 作为产物：
  描述：

  1,3,6-三羟基-2-甲基蒽醌-3-O-Α-鼠李糖-(1→2)-Β-D-(6'-O-乙酰基)-葡萄糖苷 在 水 、 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 0.17h， 生成 1,3,6-三羟基-2-甲基蒽醌-3-O-新橙皮糖苷
  参考文献：
  名称：

  [EN] COMPOSITIONS AND METHODS FOR TREATING STEROID HORMONE-RELATED DISEASES OR DISORDERS
  [FR] COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DE MALADIES OU DE TROUBLES IMPLIQUANT DES HORMONE STÉROÏDIENNES

  摘要：

  The invention relates in one aspect to the unexpected discovery that herbal extracts of the Rubia cordifolia plant are potent inhibitors of a range of receptors, proteins and enzymes implicated in the pathology of a number of common diseases and disorders. In certain embodiments, the method is useful for treating at least one disease or disorder related to a steroid hormone receptor including prostate cancer, breast cancer, ovarian cancer, lung cancer, leukemia and lymphoma. In other embodiments, the method is useful for treating at least one disease or disorder related to the expression of at least one protein selected from the group consisting of Brd4, Brd2, cyclin D1, p53, Gata3 and CD47.

  公开号：

  WO2019232146A1

文献信息

• TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION
  申请人：ETH Zurich

  公开号：EP3943085A2

  公开（公告）日：2022-01-26

  The present invention is directed to a TOMM6 (Translocase of Outer Membrane 6kDa subunit homologue; Mitochondrial import receptor subunit TOM6 homolog)-interacting plant or fungal extract comprising an anthraquinone or anthraquinone derivative, a TOMM6-interacting anthraquinone or anthraquinone derivative, and TOMM6-interacting compounds for use in the treatment or prophylaxis of a nervous system disease, atherosclerosis, Hepatitis B infection and/or human papilloma virus (HPV) infection. Furthermore, the present invention relates to a corresponding method of therapeutic or prophylactic treatment of a nervous system disease or disorder, atherosclerosis, Hepatitis B infection and/or human papilloma virus (HPV) infection, as well as to a method for the identification of a TOMM6-interacting compound or composition. Also, the present invention provides a non-human transgenic animal expressing a transgenic, preferably human TOMM6 or a TOMM6 homolog.

  本发明涉及一种TOMM6（外膜转运酶6kDa亚基同源物；线粒体输入受体亚基TOM6同源物）相互作用的植物或真菌提取物，该提取物包含蒽醌或蒽醌衍生物、与TOMM6相互作用的蒽醌或蒽醌衍生物和与TOMM6相互作用的化合物，用于治疗或预防神经系统疾病、动脉粥样硬化、乙型肝炎感染和/或人类乳头瘤病毒（HPV）感染。此外，本发明还涉及治疗或预防神经系统疾病或紊乱、动脉粥样硬化、乙型肝炎感染和/或人乳头瘤病毒（HPV）感染的相应方法，以及鉴定TOMM6-相互作用化合物或组合物的方法。此外，本发明还提供了一种表达转基因（优选人TOMM6或TOMM6同源物）的非人类转基因动物。
• [EN] COMPOSITIONS AND METHODS FOR TREATING STEROID HORMONE-RELATED DISEASES OR DISORDERS<br/>[FR] COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DE MALADIES OU DE TROUBLES IMPLIQUANT DES HORMONE STÉROÏDIENNES
  申请人：UNIV YALE

  公开号：WO2019232146A1

  公开（公告）日：2019-12-05

  The invention relates in one aspect to the unexpected discovery that herbal extracts of the Rubia cordifolia plant are potent inhibitors of a range of receptors, proteins and enzymes implicated in the pathology of a number of common diseases and disorders. In certain embodiments, the method is useful for treating at least one disease or disorder related to a steroid hormone receptor including prostate cancer, breast cancer, ovarian cancer, lung cancer, leukemia and lymphoma. In other embodiments, the method is useful for treating at least one disease or disorder related to the expression of at least one protein selected from the group consisting of Brd4, Brd2, cyclin D1, p53, Gata3 and CD47.